arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

download Export Data

Autonomix Medical, Inc.

AMIX

$1.65 ▲ +0.03 (+1.85%) at close

18 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Autonomix Medical, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -87.6% ↘

FCF / Share $-6.52

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-2.73M

↑ +18.2% —

FCF / Share Free cash flow per share

$-6.52

↓ -16223.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗
EPS Growth YoY (%)	-9752.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	75.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	44.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-664.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	84.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-534.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	71.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-100.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-7900.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-360.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	18.2% Good ↑ Good Improving Year-over-year change in net income	16.5% Good ↑ Good Improving Year-over-year change in net income	-23.6% Weak ↓ Weak Declining Year-over-year change in net income	-23.6% Weak ↑ Weak Improving Year-over-year change in net income	-23.6% Weak ↑ Weak Improving Year-over-year change in net income	41.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-212.0% Weak ↑ Weak Improving Year-over-year change in net income	-212.0% Weak ↑ Weak Improving Year-over-year change in net income	-212.0% Weak ↑ Weak Improving Year-over-year change in net income	-723.1% Weak Weak Year-over-year change in net income	-153.7% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	-16223.3% Weak Weak Year-over-year change in free cash flow	—	—	—	-753.6% Weak Weak Year-over-year change in free cash flow	—	—	—	-91.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
FCF / Net Income (x)	1.30x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.32x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗
Return on Invested Capital (%)	-87.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-116.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-93.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	70.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	199.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-102.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-86.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-69.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-95.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-33.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-52.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-161.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-76.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-86.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-675%)	-45.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-401%)	-39.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-360%)	-51.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-445%)	-47.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-416%)	-39.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-363%)	-27.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-89.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-694%)	-51.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-440%)	-70.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-573%)	15.5% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	29.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+97%)	-33.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-320%)	-102.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-780%)	-54.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-463%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	0.12x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-81%)	—	—	—	-0.26x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-143%)	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	-27.47x Weak Weak Operating income divided by interest expense Optimal: > 5x	-28.36x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-88.61x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$-3.46M	$-7.00M	$-9.93M	$-7.48M	$-8.59M	$-9.14M	$-10.69M	$-5.16M	$-6.75M	$-8.61M	$1.46M	—	—	$-865.00K	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	-0.41x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-0.50x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗
Revenue per Share (USD)	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	—	$0.00	$0.00	—	—	—	—	—
Basic EPS, GAAP (USD)	$-5.02	$0.00	$-0.02	$-0.07	$-0.05	$-0.04	$-0.07	$-0.12	$-0.01	$-0.23	$-0.01	$-0.42	$-0.00	$-0.00	$-0.00	—	—	—
Free Cash Flow per Share (USD)	$-6.52	—	$-0.02	$-0.03	$-0.04	—	—	—	$-0.00	—	—	$-0.08	$-0.00	—	—	—	—	—
Book Value per Share (USD)	$5.83	$0.02	$0.04	$0.05	$0.08	$0.15	$0.19	$0.13	$0.01	$0.39	$-0.02	$-0.20	$0.01	$0.00	$0.00	—	—	—
Tangible Book Value per Share (USD)	$5.83	$0.02	$0.04	$0.05	$0.08	$0.15	$0.19	$0.13	$0.01	$0.39	$-0.02	$-0.20	$0.01	$0.00	$0.00	—	—	—
Basic Weighted Avg Shares (shares)	543,685	—	188.07M	113.65M	65.21M	—	38.89M	23.89M	396.95M	—	289.78M	14.44M	270.58M	—	251.98M	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗
Working Capital (USD)	$3.15M	$5.88M	$8.54M	$6.41M	$7.01M	$7.90M	$9.69M	$4.10M	$6.31M	$8.61M	$712.00K	—	—	$644.00K	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	$1.46M	—	—	—	—	—	—	—
Total Equity (USD)	$3.16M	$5.89M	$8.56M	$6.45M	$7.03M	$8.10M	$9.71M	$3.03M	$5.29M	$7.63M	$-5.59M	$-2.92M	$2.62M	$644.00K	$626.00K	$1.17M	$1.62M	$1.96M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2027 Jun 30, 2026 10-Q ↗	Q4 FY2026 Mar 31, 2026 10-K ↗	Q3 FY2026 Dec 31, 2025 10-Q ↗	Q2 FY2026 Sep 30, 2025 10-Q ↗	Q1 FY2026 Jun 30, 2025 10-Q ↗	Q4 FY2025 Mar 31, 2025 10-K ↗	Q3 FY2025 Dec 31, 2024 10-Q ↗	Q2 FY2025 Sep 30, 2024 10-Q ↗	Q1 FY2025 Jun 30, 2024 10-Q ↗	Q4 FY2024 Mar 31, 2024 10-K ↗	Q3 FY2024 Dec 31, 2023 10-Q ↗	Q2 FY2024 Sep 30, 2023 10-Q ↗	Q1 FY2024 Jun 30, 2023 10-Q ↗	Q4 FY2023 Mar 31, 2023 10-K ↗	Q3 FY2023 Dec 31, 2022 10-Q ↗	Q2 FY2023 Sep 30, 2022 10-Q ↗	Q1 FY2023 Jun 30, 2022 10-Q ↗	Q4 FY2022 Mar 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	—	—	—	—
Depreciation Expense (USD)	$3.00K	$3.00K	$4.00K	$2.00K	$3.00K	$48.00K	—	—	$43.00K	—	—	$0.00	$0.00	$0.00	—	—	—	—
Net Income, GAAP (USD)	$-2.73M	$-2.67M	$-3.34M	$-3.34M	$-3.34M	$-3.19M	$-2.70M	$-2.70M	$-2.70M	$-5.41M	$-865.00K	$-865.00K	$-865.00K	$-657.00K	$-341.00K	—	—	—
Operating Cash Flow (USD)	$-3.54M	$-2.89M	$-2.97M	$-3.82M	$-2.60M	$-2.51M	—	—	$-1.85M	$-2.24M	—	$-1.14M	$-661.00K	$-620.00K	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 5 years · 18 quarters

Autonomix Medical, Inc.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AMIX with peers